Skip to main content
OpenTrials

Clinical trial condition

Metabolic Diseases

Explore clinical trials studying Metabolic Diseases. Study availability and eligibility vary by location and protocol.

29,077 public trials 3,242 recruiting studies
Refine in advanced search Browse all conditions

Metabolic Diseases trial results

Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

NCT07282600

Conditions
Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +10 more
Locations
  • Birmingham Clinical Research Birmingham, Alabama, United States
  • Cullman Clinical Trials Cullman, Alabama, United States
  • Tucson Clinical Research Institute Tucson, Arizona, United States
  • San Fernando Valley Health Institute Canoga Park, California, United States
View all 157 locations
View Trial Details
Recruiting

Alpha-Synuclein PET/CT in Various α-Syn-Related Disease

NCT06949670

Conditions
Alpha Synuclein Pathology, Alpha-Synuclein, Basal Ganglia Diseases, +12 more
Locations
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

NCT05040373

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +15 more
Locations
  • Clinical Trial Site Iowa City, Iowa, United States
  • Clinical Trial Site Nantes, France
  • Clinical Trial Site Münster, Germany
  • Clinical Trial Site Pavia, Italy
View Trial Details
Recruiting

Li-Fraumeni Syndrome/TP53 Biobank

NCT04367246

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +6 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Children's Hospital of Philadelphia Phildelphia, Pennsylvania, United States
View Trial Details
Recruiting

Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia

NCT04447911

Conditions
Brain Diseases, Central Nervous System Diseases, Digestive System Diseases, +21 more
Locations
  • University Hospital of Würzburg, med. Poliklinik Würzburg, Germany
  • Erasmus Universität Medisch Centrum Rotterdam, Department of Internal Medicine Rotterdam, Netherlands
  • Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Canton of Vaud, Switzerland
  • University Hospital Basel Basel, Switzerland
View Trial Details

Related conditions